Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia

Journal of Association of Physicians of India

Volumn 56, Issue DEC., 2008, Pages 942-944

  Ghalaut, P S ^a   Sen, R ^a   Dixit, G ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD DISEASE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; FEMALE; FEVER; HUMAN; INCIDENCE; INFECTION; LENGTH OF STAY; LEUKEMIA; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHIL; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; INFECTION; LENGTH OF STAY; LEUKEMIA; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 57349111100     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hubel A, Engert A. Clinical application of G-CSF an update and summary. Ann Hematol 2003;82:207-13.
2. Nissen C, Carbonare VD, Moser Y. In vitro comparison of the biological potency of glycosylated versus nonglycosylated rG-CSF. Drug Invest 1994;7:346-52.
3. Dale DC. CSF for the management of neutropenia in cancer patient. Drugs 2002;62:1-1 5.
4. Page RD, Smith FP, Geils GF, Beall CL, Fridman M, Allen BJ. Dose dense vinorelbine and docetaxel with filgrastim support in patients with advanced non small cell lung carcinoma retrieved. Sept. 21, 2005. From Wiley Interscience. www.interscience.wiley.com
5. Ozer H, Armitage JO, Benett CL, Crawford J, Demetri GD, Pizzo PA, et al. Update of recommendations for use of hematopoietic colony-stimulating factors: evidence based, clinical practice guidelines. Expert Panel. J Clin Oncol 2000;18:3558-85.
6. Neopogen. Prescribing information. Retrieved April 11, 2006. From http://www.neopogen.com/pi.html
7. Schriber J. Treatment of aggressive non-Hodgkin's lymphoma with chemotherapy in combination with filgrastim. Drugs 2002;62(1):33-46.
8. Heil G, Hoelzer D, Sanz MA, et al. A randomized, double blind, placebo-controlled phase III study of G-CSF in remission induction and consideration therapy for adults with de novo acute myeloid leukemia. Blood 1997;90:4710-8.
9. Larson RA, Dodge RK, Linker CA, et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia. CALGB study 9111. Blood 1998;92:1556-64.
10. Carbonero GR, Mayordomo JI, Tornamira MV, Lopez BM, Rueda A, Guillem V. Granulocyte colony stimulating factor in the treatment of high risk febrile neutropenia: a multicenter randomized trial. J Natl Cancer Inst 2001;93:31-8.
11. Hartmann LC, Tschetter LK, Habermann TM, et al. Granulocyte colony stimulating factor in severe chemotherapy induced afebrile neutropenia. New Engl J Med 1997;336:1776-80.